Foundry Partners’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
Other funds holding SNY
Foundry Partners's SNY Position: Q2 2024 in Review
Foundry Partners sold out of Sanofi (SNY) in Q2 2024, closing a stake of 159,556 shares — an estimated $7.75M sold.
Foundry Partners first reported a position in SNY in Q1 2015 and held it in 13 quarters. The position peaked at $21.5M in Q1 2023. 730 funds tracked by Wall St. Rank hold SNY as of Q2 2024.
- Foundry Partners reported no remaining Sanofi position as of Q2 2024 after selling out during the quarter.
- Foundry Partners sold 159,556 Sanofi shares in Q2 2024, an estimated $7.75M.
- Foundry Partners first reported a position in Sanofi in Q1 2015 and held it in 13 quarters.
- Foundry Partners's Sanofi position peaked at $21.5M in Q1 2023.
- 730 funds tracked by Wall St. Rank held Sanofi as of Q2 2024.
Based on Foundry Partners's 13F filing for Q2 2024, filed 5 Aug 2024.